RAP: RAPAMYCIN IMMUNOSUPPRESSANT DRUG
RAP is a Ligand Of Interest in 2DG3 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 2DG3_RAP_A_501 | 59% | 40% | 0.124 | 0.907 | 1.1 | 1.14 | 4 | 6 | 0 | 0 | 100% | 1 |
| 6M4U_RAP_A_201 | 79% | 34% | 0.102 | 0.952 | 1.83 | 0.74 | 1 | 2 | 0 | 0 | 100% | 1 |
| 6M4V_RAP_D_201 | 52% | 39% | 0.194 | 0.956 | 1.01 | 1.26 | 3 | 6 | 2 | 0 | 100% | 1 |
| 2DG9_RAP_A_501 | 50% | 41% | 0.14 | 0.892 | 1.11 | 1.08 | 4 | 5 | 3 | 0 | 100% | 1 |
| 2DG4_RAP_A_501 | 46% | 42% | 0.138 | 0.874 | 1.08 | 1.06 | 3 | 6 | 0 | 0 | 100% | 1 |
| 6M4W_RAP_D_201 | 35% | 33% | 0.256 | 0.953 | 1.82 | 0.8 | 1 | 3 | 1 | 0 | 100% | 1 |
| 4DRJ_RAP_A_201 | 97% | 39% | 0.049 | 0.969 | 1.23 | 1.08 | 5 | 5 | 2 | 0 | 100% | 1 |
| 4QT3_RAP_A_202 | 94% | 46% | 0.063 | 0.967 | 0.97 | 1 | 3 | 3 | 0 | 0 | 100% | 1 |
| 4QT2_RAP_A_202 | 90% | 4% | 0.069 | 0.956 | 2.88 | 2.52 | 11 | 20 | 0 | 0 | 100% | 1 |
| 4DRI_RAP_A_201 | 86% | 41% | 0.082 | 0.957 | 1.04 | 1.15 | 3 | 6 | 0 | 0 | 100% | 1 |
| 5HKG_RAP_A_201 | 85% | 63% | 0.073 | 0.943 | 0.53 | 0.74 | 1 | 1 | 0 | 0 | 100% | 1 |
